The State of the Art in Apheresis
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Join Dr Shira Johnson as she interviews Dr Sergio Torloni from the Mayo Clinic. Dr Torloni is the Medical Director responsible for theraputic apheresis, stem cell manipulation, and treatment of coagulopathies. He is on the cutting edge of this scientific breakthrough technology utilized in research and treatment.
Overview
Join Dr Shira Johnson as she interviews Dr Sergio Torloni from the Mayo Clinic. Dr Torloni is the Medical Director responsible for theraputic apheresis, stem cell manipulation, and treatment of coagulopathies. He is on the cutting edge of this scientific breakthrough technology utilized in research and treatment.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Innovations in the Management of Hemolytic Disease of the Fetus and Newborn: The Role of the Neonatal Fc Receptor (FcRn) Pathway
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
HF Management for Patients with Comorbid Conditions
Clinical Conundrums in ARIA: 1. Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
Navigating Myasthenia Gravis in Adolescents and Young Adults
Understanding hypertrophic cardiomyopathy and recent guidelines
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?